A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

In his 2025 to 2026 term as American Academy of Allergy, Asthma & Immunology president, Frank S. Virant, MD, FAAAAI, plans to ...

In this Healio Video Perspective from Hawaiian Eye 2025, Richard Small, CEO of Neurotech Pharmaceuticals, discusses the ...

In this video, Marlise R. Luskin, MD, MSCE, highlights updates from two groups evaluating blinatumomab and ponatinib for the treatment of acute lymphoblastic leukemia.

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment ...

In this video, Marlise R. Luskin, MD, MSCE, discusses results from a phase 3 randomized trial that investigated the addition of blinatumomab to standard chemotherapy for pediatric B-cell acute ...

Undergraduate medical schools show “significant variation” in rheumatology training, with some students receiving as few as 4 ...

A qualitative study yielded important insights about how patients, caregivers and clinicians define what truly is clinically ...

World Cancer Day will be observed Feb. 4.Union for International Cancer Control (UICC) created World Cancer Day in 2000 to ...

Also, if you're more of a mobile app user, there is a CDC Vaccine Schedules app, which can be downloaded, and that can be utilized on your mobile device for easy access as a resource to help keep up ...

There are multiple strategies that physicians and clinicians can use to address the important issue of vaccine hesitancy. But let me start first by defining exactly what vaccine hesitancy is. There's ...

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.